The development of drug-eluting stents is reviewed in this paper.
就药物涂层支架的最新进展做一综述。
The stated purpose of the FDA meeting is to weigh the risks and benefits of drug-eluting stents.
FDA会议的目的就是衡量药物包衣支架系统的利弊。
Background The long-term safety and efficacy of drug-eluting coronary stents have been questioned.
药物洗脱冠脉支架的长期安全性和有效性尚存疑问。
From 1998 to 2005 the use of equipment such as defibrillators and drug-eluting stents expanded rapidly.
从1998年到2005年，诸如心脏除颤器，药物涂层支架这样的设备普及的越来越快。
Attention has recently been focused on late stent thrombosis related to the use of drug-eluting stents.
但最近药物支架晚期血栓的问题倍受关注。
The drug-eluting stents were introduced to solve this problem by releasing a drug that prevents cell growth.
药物可释性支架可解决这一问题，它可以通过释放相关药物阻止细胞生长。
Drug-eluting stents are coated with a drug that helps keep the blood vessels from re-closing around the device.
药物包衣支架外包裹的药物能防止装置周围的血管再闭。
Conclusion Drug-eluting stent implantation can decrease the rate of restenosis significantly in coronary intervention.
结论药物涂层支架置入可显著降低冠脉介入术后再狭窄率。
Increasingly doctors use what is called a drug-eluting stent. This kind has medicine on it that is released slowly over time.
医生使用一种叫做药物洗提的管状物日益增加，这种类型的管状物有药物在里面，随着时间的推移慢慢地释放。
"The rates of drug efflux that we got from these are vastly more than any other drug-eluting lens that we are familiar with," Kohane said.
科汉解释说，我们得到的药物释放率远远超过我们熟知的其他药物释放镜片。
On the other hand, restenosis developed in 47% of patients, versus reported rates of 28% for bare metal stents and 6% after drug-eluting stents.
另一方面，47%的患者出现了再狭窄，而应用裸支架的患者再狭窄发生率据报道是28%，而应用涂层支架的是6%。
According to one estimate, published by Bloomberg News, drug-eluting stents may be causing an extra 2,160 deaths in the United States each year.
按照Bloomberg新闻的一项评估显示，药物包衣支架在美国每年可能导致了2160例死亡。
The approach also could be used to improve "drug-eluting stents," which are metal scaffolds inserted into arteries to keep them open after surgeries to treat clogs.
这种支架可以在血管再通手术后维持血管通畅，并在植入后释放相关治疗药物。
OBJECTIVE: To investigate how to elevate the compatibility of drug-eluting stent in elderly cardiovascular disease from aspects of material and clinical application.
目的：从材料学及临床应用方面阐述如何提高老年心血管疾病中药物涂层支架的相容性。
This article reviews the clinical evidence and pathophysiological mechanisms of stent thrombosis of drug-eluting stent, especially the role of the stent itself in it.
现对药物涂层支架内血栓形成的相关临床证据和病理生理机制，特别是药物涂层支架本身在其中的作用进行综述。
OBJECTIVE: To understand the types and characteristics of anti-proliferative drug-eluting stent, and its effectiveness in clinical applications and problems to be solved.
目的：了解抗增殖作用药物涂层支架的种类和特点及其在临床应用中的有效性和亟待解决的问题。
Objective To study the incidence of major cardiovascular events by observing the clinical outcome of the first-generation drug-eluting stents (DES) 5 years after implantation.
目的研究第一代药物洗脱支架治疗冠心病远期(5年)临床疗效。
The implantation of a drug-eluting stent is one of the main methods for treating coronary heart disease, but the occurrence of thrombogenesis after implantation remains a problem.
药物洗脱支架置入是目前治疗冠心病的主要方式，但血栓形成仍是目前关注的主要问题。
Background: The safety and efficacy of drug-eluting stents among more generalized "real-world" patients than those enrolled in pivotal randomized controlled trials are controversial.
背景：与中心随机对照试验相比，在广泛的“真实世界”患者中应用更多的药物洗脱支架的安全性和有效性具有争议。
Objective Compare drug-eluting stent (DES) to bare-metal stent(BMS) in prognosis on treating diffuse coronary lesions and analysis risk factor of treating complex and diffuse lesions in PCI.
目的比较冠心病患者弥漫病变采用药物洗脱支架和金属裸支架治疗的近期和远期预后，分析影响这类病变介入治疗预后的危险因素。
International Circulation: This leads into my next question. For patients with left main lesion or multi-vessel lesions, obviously there are different opinions on CABG or drug-eluting stents.
国际循环：目前对于无保护左主干病变，究竟是置入药物洗脱支架还是CABG治疗对患者获益更大还存在争议。
Objective to study the related factors and prognosis of rapamycin drug-eluting stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
目的：探讨ST段抬高性心肌梗死患者经皮冠状动脉介入置入雷帕霉素药物洗脱支架内血栓形成的相关因素及预后。
Heterogeneity of healing is a common finding in drug-eluting stents with evidence of LST and demonstrates the importance of incomplete healing of the stented segment in the pathophysiology of LST.
愈合的不均一性在有lst证据的药物洗脱支架中很常见，这种不均一性也证实了支架部分不完全愈合在LST发病的病理生理学上的重要性。
Angiographic measurements in both groups showed that patients who had drug-eluting stents experienced less than half as much restenosis (14.5 percent) as those who had brachytherapy (31.2 percent).
各组血管造影的结果证明接受紫杉醇释放支架治疗的患者出现并发症的几率(14.5%)比放射疗法(31.2%)几乎少了一半。
Right now, we try to keep dual anti-platelet therapy going for up to one year in patients who have a drug-eluting stent because we are very concerned about the possibility of late-stent thrombosis.
目前，对于接受药物洗脱支架的患者，我们尝试维持双重抗血小板治疗在一年以上，因为我们非常关注晚期支架内血栓形成的可能性。
NEW DATA showing increased mortality rates associated with drug eluting stents (DES) in acute coronary syndromes were presented in a Hot Line Session yesterday.
昨日一个热点会议发布，新的研究数据表明与药物洗脱支架(DES)有关的急性冠状动脉综合征死亡率不断增加。
Mortality rates in patients with drug eluting stents (DES) are no higher than with bare metal stents (BMS), according to the largest ever long-term study of DES and BMS.
目前一项最大的药物洗脱支架(DES)与金属裸支架(BMS)长期研究显示，植入DES的患者死亡率并未高于植入BMS的患者。
In-stent restenosis has been significantly reduced by utilization of drug eluting stents.
药物涂层支架的应用显著降低了支架内再狭窄的发生。
Objective To investigate the clinical effects, safety and cost of domestic and imported drug eluting stents in patients undergoing treatment of acute myocardial infarction.
目的调查和分析在急性心肌梗死患者治疗过程中，国产与进口药物支架的临床应用效果、安全性和产生费用。
Objective To investigate the clinical effects, safety and cost of domestic and imported drug eluting stents in patients undergoing treatment of acute myocardial infarction.
目的调查和分析在急性心肌梗死患者治疗过程中，国产与进口药物支架的临床应用效果、安全性和产生费用。
应用推荐